These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9578045)

  • 21. [Lamotrigine in the adult-onset epilepsy: efficacy and long-term safety].
    Alegre M; Iriarte J; Schlumberger E; Urrestarazu E; Lázaro D; Viteri C
    Neurologia; 2002 Mar; 17(3):136-42. PubMed ID: 11927102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability and pharmacokinetics of oral loading with lamotrigine in epilepsy monitoring units.
    Lardizabal DV; Morris HH; Hovinga CA; Del Mar Carreño M
    Epilepsia; 2003 Apr; 44(4):536-9. PubMed ID: 12681002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of lamotrigine on sleep in patients with epilepsy.
    Foldvary N; Perry M; Lee J; Dinner D; Morris HH
    Epilepsia; 2001 Dec; 42(12):1569-73. PubMed ID: 11879368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.
    Aberg LE; Bäckman M; Kirveskari E; Santavuori P
    Epilepsia; 2000 Oct; 41(10):1296-302. PubMed ID: 11051125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of an intravenous formulation of lamotrigine.
    Conway JM; Birnbaum AK; Leppik IE; Pennell PB; White JR; Rarick JO; Remmel RP
    Seizure; 2014 May; 23(5):390-2. PubMed ID: 24560492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
    Eriksson AS; Nergårdh A; Hoppu K
    Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saliva and serum concentration of lamotrigine in patients with epilepsy.
    Tsiropoulos I; Kristensen O; Klitgaard NA
    Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
    Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
    Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine.
    Matsuo F
    Epilepsia; 1999; 40 Suppl 5():S30-6. PubMed ID: 10530692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
    Saetre E; Perucca E; Isojärvi J; Gjerstad L;
    Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
    Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
    Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of long-term lamotrigine in epilepsy.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamotrigine and seizure aggravation in severe myoclonic epilepsy.
    Guerrini R; Dravet C; Genton P; Belmonte A; Kaminska A; Dulac O
    Epilepsia; 1998 May; 39(5):508-12. PubMed ID: 9596203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy.
    Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP
    Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamotrigine-induced tic disorder: report of five pediatric cases.
    Sotero de Menezes MA; Rho JM; Murphy P; Cheyette S
    Epilepsia; 2000 Jul; 41(7):862-7. PubMed ID: 10897158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
    Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K
    Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.